Roche Diagnostics has appointed Ketan Paranjape vice president of diagnostics information solutions. He will oversee the company’s new DIS commercial business. In his new role, Paranjape will establish commercialization strategies to market Roche’s digital software solutions. The DIS business aims to harness the power of data, diagnostics and other critical information to support better clinical decisions.

He previously served as managing director of business development for Health2047, a startup integrated innovation company whose mission is to develop, guide and commercialize disruptive ideas that enhance the practice of healthcare. At Health2047, Paranjape combined medicine, health care,strategy, design, engineering, product, technology, corporate development, finance and venture disciplines with access to the American Medical Association’s expertise and connectivity to physicians nationwide to create meaningful market impact.

He also previously worked at Intel for 20 years. There, he held a variety of roles with increasing levels of responsibility. Paranjape joined the company as head of product in 1997 and most recently served as vice president and general manager, health and life sciences, a division of the company he started in 2011.

He is also founder of Shankar Health Foundation. The foundation builds, establishes and deploys platforms for telemedicine and remote patient monitoring and is currently serving more than 100 clinics in India, Sri Lanka, Vietnam, Laos and Cambodia.

Paranjape has an MBA in finance and marketing from the University of Oregon, where he was class valedictorian. He also earned two master’s degrees from the University of Wisconsin; one in biomedical engineering, the other in computer sciences. At the University of Pune, Paranjape earned his bachelor’s degree in electrical engineering. Additionally, he is a graduate of the Stanford Executive Program and a visiting faculty member for Harvard’s School of Public Health and Oregon’s Health and Science University.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}